134 related articles for article (PubMed ID: 12227128)
1. Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis.
Richter B; Neises G; Clar C
Endocrinol Metab Clin North Am; 2002 Sep; 31(3):699-722. PubMed ID: 12227128
[TBL] [Abstract][Full Text] [Related]
2. Thyroxine suppressive therapy in patients with nodular thyroid disease.
Gharib H; Mazzaferri EL
Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
[TBL] [Abstract][Full Text] [Related]
3. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
Bennedbaek FN; Nielsen LK; Hegedüs L
J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
[TBL] [Abstract][Full Text] [Related]
4. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.
Castro MR; Caraballo PJ; Morris JC
J Clin Endocrinol Metab; 2002 Sep; 87(9):4154-9. PubMed ID: 12213864
[TBL] [Abstract][Full Text] [Related]
7. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial.
Koc M; Ersoz HO; Akpinar I; Gogas-Yavuz D; Deyneli O; Akalin S
Clin Endocrinol (Oxf); 2002 Nov; 57(5):621-8. PubMed ID: 12390336
[TBL] [Abstract][Full Text] [Related]
8. Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis.
Csako G; Byrd D; Wesley RA; Sarlis NJ; Skarulis MC; Nieman LK; Pucino F
Medicine (Baltimore); 2000 Jan; 79(1):9-26. PubMed ID: 10670406
[TBL] [Abstract][Full Text] [Related]
9. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
10. [Levothyroxine treatment of the solitary thyroid nodule].
Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of thyroid nodule growth.
Quadbeck B; Pruellage J; Roggenbuck U; Hirche H; Janssen OE; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):348-54. PubMed ID: 12397534
[TBL] [Abstract][Full Text] [Related]
12. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials.
Sdano MT; Falciglia M; Welge JA; Steward DL
Otolaryngol Head Neck Surg; 2005 Sep; 133(3):391-6. PubMed ID: 16143188
[TBL] [Abstract][Full Text] [Related]
14. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
16. Levothyroxine suppressive therapy for solitary thyroid nodule.
Mainini E; Martinelli I; Morandi G; Villa S; Stefani I; Mazzi C
J Endocrinol Invest; 1995 Nov; 18(10):796-9. PubMed ID: 8787957
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study.
Cheung PS; Lee JM; Boey JH
World J Surg; 1989; 13(6):818-21; discussion 822. PubMed ID: 2696232
[TBL] [Abstract][Full Text] [Related]
18. Suppressive therapy with levothyroxine for solitary thyroid nodules.
Reverter JL; Lucas A; Salinas I; Audí L; Foz M; Sanmartí A
Clin Endocrinol (Oxf); 1992 Jan; 36(1):25-8. PubMed ID: 1559296
[TBL] [Abstract][Full Text] [Related]
19. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
